Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Clinical significance of Arg306 mutations of factor V gene.

Liang R, Lee CK, Wat MS, Kwong YL, Lam CK, Liu HW.

Blood. 1998 Oct 1;92(7):2599-600. No abstract available.

2.

The prevalence of factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in different human populations.

Franco RF, Elion J, Tavella MH, Santos SE, Zago MA.

Thromb Haemost. 1999 Feb;81(2):312-3. No abstract available.

PMID:
10064012
3.

Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors--correlation with absence of Arg506-Gln mutation of factor V gene.

Chan LC, Bourke C, Lam CK, Liu HW, Brookes S, Jenkins V, Pasi J.

Thromb Haemost. 1996 Mar;75(3):522-3. No abstract available.

PMID:
8701422
4.

A new factor V gene polymorphism (His 1254 Arg) present in subjects of african origin mimics the R2 polymorphism (His 1299 Arg)

Lunghi B, Castoldi E, Mingozzi F, Bernardi F.

Blood. 1998 Jan 1;91(1):364-5. No abstract available.

5.

High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.

Zöller B, Norlund L, Leksell H, Nilsson JE, von Schenck H, Rosén U, Jepsson JO, Dahlbäck B.

Thromb Res. 1996 Sep 15;83(6):475-7. No abstract available.

PMID:
8885142
6.
7.

A novel mutation of Arg306 of factor V gene in Hong Kong Chinese.

Chan WP, Lee CK, Kwong YL, Lam CK, Liang R.

Blood. 1998 Feb 15;91(4):1135-9.

8.

Absence of factor V Arg306--Thr and low factor V Arg306->Gly mutation prevalence in Thai blood donors.

Chuansumrit A, Jarutwachirakul W, Sasanakul W, Rurgkhum S, Kadegasem P, Kitpoka P, Sirachainan N.

Southeast Asian J Trop Med Public Health. 2004 Jun;35(2):450-2.

PMID:
15691154
9.

Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.

Dahlbäck B.

Rev Invest Clin. 1997 May;49 Suppl 1:3-5. Review. No abstract available.

PMID:
9291738
10.

Detection of the factor V Leiden mutation in a nonselected black population.

Pottinger P, Sigurdsson F, Berliner N.

Blood. 1996 Mar 1;87(5):2091. No abstract available.

11.

A Thai patient with the mutation of Arg306 of FV gene identical to the Hong Kong but not to the Cambridge type.

Hiyoshi M, Hashimoto S, Tagawa S, Arnutti P, Prayoonwiwat W, Tatsumi N.

Thromb Haemost. 1999 Nov;82(5):1553-4. No abstract available.

PMID:
10595653
12.

Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency.

van Wijk R, Nieuwenhuis K, van den Berg M, Huizinga EG, van der Meijden BB, Kraaijenhagen RJ, van Solinge WW.

Blood. 2001 Jul 15;98(2):358-67.

13.

Rapid detection of factor V Leiden (FVQ506) by non-radioactive single strand conformation polymorphism (SSCP).

Arruda VR, von Zuben PM, Annichino-Bizzachi JM, Costa FF.

Sangre (Barc). 1996 Oct;41(5):379-81.

PMID:
8986114
14.

Prevalence of Factor V Leiden in three ethnic groups of patients with deep vein thrombosis in the Western Cape province of South Africa.

Rubinstein R, Kolia F, Novitzky N.

Eur J Haematol. 2000 Jul;65(1):78-9. No abstract available.

PMID:
10914945
15.

Inherited homozygous resistance to activated protein C.

Villa P, Aznar J, Jorquera J, Mira Y, Vayá A, Fernández MA.

Thromb Haemost. 1995 Aug;74(2):794-5. No abstract available.

PMID:
8585025
16.

Homozygous factor V splice site mutation associated with severe factor V deficiency.

Schrijver I, Koerper MA, Jones CD, Zehnder JL.

Blood. 2002 Apr 15;99(8):3063-5.

17.

The factor V gene A4070G mutation and the risk of venous thrombosis.

Alhenc-Gelas M, Nicaud V, Gandrille S, van Dreden P, Amiral J, Aubry ML, Fiessinger JN, Emmerich J, Aiach M.

Thromb Haemost. 1999 Feb;81(2):193-7.

PMID:
10063990
18.

High frequency of factor V Leiden mutation and prothrombin 20210A variant in Romanies of Eastern Hungary.

Balogh I, Póka R, Losonczy G, Muszbek L.

Thromb Haemost. 1999 Nov;82(5):1555-6. No abstract available.

PMID:
10595655
19.

The activated protein C (APC)-resistant phenotype of APC cleavage site mutants of recombinant factor V in a reconstituted plasma model.

van der Neut Kolfschoten M, Dirven RJ, Tans G, Rosing J, Vos HL, Bertina RM.

Blood Coagul Fibrinolysis. 2002 Apr;13(3):207-15.

PMID:
11943934
20.

Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?

Biswas A, Bajaj J, Ranjan R, Meena A, Akhter MS, Yadav BK, Sharma V, Saxena R.

Clin Chim Acta. 2008 Jun;392(1-2):21-4. doi: 10.1016/j.cca.2008.02.018. Epub 2008 Feb 25.

PMID:
18342013

Supplemental Content

Support Center